Intensive glucose control and macrovascular outcomes in type 2 diabetes

Top Cited Papers

5 August 2009

journal article
research article
Published by Springer Nature in Diabetologia

Vol. 52 (11) , 2288-2298
https://doi.org/10.1007/s00125-009-1470-0

Abstract

Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, compared with less-intensive, glucose control on the risk of major cardiovascular events amongst patients with type 2 diabetes.

Keywords

This publication has 18 references indexed in Scilit:

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
New England Journal of Medicine, 2009
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
New England Journal of Medicine, 2008
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine, 2008
Effects of Intensive Glucose Lowering in Type 2 Diabetes
New England Journal of Medicine, 2008
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus
Circulation, 2007
Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study
The Lancet Neurology, 2005
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
BMJ, 2005
Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?
Diabetes Care, 2003
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
The Lancet, 1998
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
BMJ, 1998